AT
Akash Tewari Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
10
Avg Return
Past Year
Past Year
69%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $138 |
65%
upside
| 1 | -18% |
0
%
| 10 Mar ‘26 5 hours ago |
|
|
|
Buy
Initiated
| $580 |
16%
upside
| 1 | +8.3% |
0
%
| 10 Mar ‘26 11 hours ago |
|
|
|
Hold
Initiated
| $350 |
7%
downside
| 1 | – |
–
| 10 Mar ‘26 11 hours ago |
|
|
|
Buy
Initiated
| $180 |
21%
upside
| 1 | +1.3% |
0
%
| 10 Mar ‘26 12 hours ago |
|
|
|
Buy
Maintained
| $35 |
23%
downside
| 1 | +448% |
0
%
| 3 Nov ‘25 4 months ago |
|
|
|
Buy
Maintained
| $96 |
27%
upside
| 1 | +77% |
0
%
| 2 Sep ‘25 6 months ago |
|
|
|
Buy
Maintained
| $831 |
8%
upside
| 1 | +31% |
0
%
| 27 Aug ‘25 6 months ago |
|
|
|
Buy
Initiated
| $26 |
107%
upside
| 1 | -17% |
0
%
| 25 Aug ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $10 |
28%
downside
| 1 | – |
–
| 2 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $68 |
13%
upside
| 1 | +21% |
0
%
| 23 Apr ‘25 10 months ago |
|